<?xml version="1.0" encoding="UTF-8"?>
<div class="fig" id="PMC2802127/figure_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption> Efficacy of HBPG against HSV-2 encephalitis in mice after various delays in starting dosing post-infection. HBPG was given twice daily for five days. Notes: For reduction of mortality, P &lt; 0.05 at one and two days postinfection (Fisher’s exact test). For MDD, P &lt; 0.05 at one and two days postinfection (Mann–Whitney U test). Abbreviations: HBPG, 2-phenylamino-6-oxo-9-(4-hydroxybutyl)purine; HSV, herpes simplex virus; MDD, mean day of death. </caption>
 <div class="graphic"/>
 <p class="label">Figure 1</p>
</div>
